[Across-sectional study on the association between steatotic liver disease and its subtypes, cardiovascular health status, and extrahepatic comorbidity]. [PDF]
Guan JB +8 more
europepmc +1 more source
[Exploration of the mechanisms of portal hypertension driven by metabolic disorders in non-cirrhotic stages of metabolic-associated fatty liver disease]. [PDF]
Zhao YQ, Wang Y, Liu JJ, You H, Zhao JJ.
europepmc +1 more source
[A review of research progress in integrated traditional Chinese and Western Medicine for liver diseases]. [PDF]
Zhang Q +6 more
europepmc +1 more source
[Research progress on the effects of time-restricted eating on metabolic associated fatty liver disease]. [PDF]
Jiang ZQ, Wei TJ, Li GX.
europepmc +1 more source
[Introduction to the recommendations of the EASL clinical practice guidelines for genetic cholestatic liver diseases]. [PDF]
Hou W, Zheng SJ.
europepmc +1 more source
[Recommendations from the European Association for the Study of the Liver and the European Reference Network for Rare Liver Diseases Clinical Practice Guidelines for hepatolenticular degeneration]. [PDF]
Tang S, Hou W, Zheng SJ.
europepmc +1 more source
[Interpretation of key updates of the 2026 version of the APASL clinical practice guidelines for the management of chronic hepatitis B]. [PDF]
Liu HS, Ai XW, Sun YM, You H.
europepmc +1 more source
[Periodontitis and Metabolic Dysfunction-Associated Fatty Liver Disease: From Oral Dysbiosis to Hepatic Metabolic Dysregulation]. [PDF]
Wang M +5 more
europepmc +1 more source
[Application and prospects of artificial intelligence from tool empowerment to paradigm reconstruction for whole-course diagnosis and treatment of liver diseases by ultrasound]. [PDF]
Huang JY, Xu QQ, Chen LD, Wang W.
europepmc +1 more source
[Inherited metabolic liver disease causing copper deposition]. [PDF]
Jiang H, Liang C, Liu H, Zheng SJ.
europepmc +1 more source

